Press "Enter" to skip to content

The content provided here is for informational and educational purposes only and does not constitute investment advice, a recommendation, an offer or solicitation to buy or sell any financial instrument, security, cryptocurrency, or investment product. Nothing in this material should be construed as personalized financial, tax, legal, or other professional advice tailored to your individual circumstances. Prior to making any investment or financial decisions you should consult with a qualified financial adviser, tax professional, or other relevant expert who can take into account your specific objectives and circumstances.

Markets are inherently uncertain and past performance is not indicative of future results. Prices can move quickly and unpredictably due to a wide range of factors, including economic data, monetary policy decisions, geopolitical events, regulatory changes, issuer-specific news, liquidity conditions, and technological developments. Cryptocurrencies and other digital assets in particular are subject to extreme volatility, rapid regulatory shifts, cyber security risks, and the potential for total loss. Do not invest funds you cannot afford to lose.

Home » Pharmaceuticals

Posts tagged as “Pharmaceuticals”

Tonix’s Tonmya Surpasses 4,200 Scripts, Beats Chronic Pain Launch Expectations $TNXP $XBI

By STOCKREPORT on March 13, 2026

Tonix Pharmaceuticals’ Tonmya Exceeds Early Commercial Expectations Tonix Pharmaceuticals Holding Corp. has reported a significant early milestone for its chronic pain drug Tonmya, with prescriptions…

India’s ₹10,000 Crore Biopharma SHAKTI Initiative Unveiled

By STOCKREPORT on February 9, 2026

India’s ₹10,000 Crore Biopharma SHAKTI Initiative Unveiled

#Biopharma #India #Healthcare #Innovation #Pharmaceuticals India’s ₹10,000 Crore Biopharma SHAKTI Initiative Unveiled In a significant move to bolster India’s biopharmaceutical sector, Finance Minister Nirmala Sitharaman…